Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.

Saved in:
Bibliographic Details
Title: Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
Authors: Sasi BK; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Tarantelli C; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Martindale S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Civanelli E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Cannas E; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Sartori G; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Arribas AJ; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona., Fernandes SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Shupe SJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Machado JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts., Tyekucheva S; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ren Y; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Lahn M; iOnctura SA; Geneva., Van der Veen L; iOnctura BV; Amsterdam, Netherlands., Di Conza G; iOnctura SA; Geneva., Bertoni F; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale; Bellinzona. francesco.bertoni@ior.usi.ch., Brown JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts, USA; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Boston, MA. jennifer_brown@dfci.harvard.edu.
Source: Haematologica [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 2974-2985. Date of Electronic Publication: 2025 Jun 19.
Publication Type: Journal Article
Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40534489
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sasi+BK%22">Sasi BK</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tarantelli+C%22">Tarantelli C</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Martindale+S%22">Martindale S</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Civanelli+E%22">Civanelli E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Cannas+E%22">Cannas E</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Sartori+G%22">Sartori G</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Arribas+AJ%22">Arribas AJ</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona.<br /><searchLink fieldCode="AU" term="%22Fernandes+SM%22">Fernandes SM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shupe+SJ%22">Shupe SJ</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Machado+JH%22">Machado JH</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tyekucheva+S%22">Tyekucheva S</searchLink>; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ren+Y%22">Ren Y</searchLink>; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Lahn+M%22">Lahn M</searchLink>; iOnctura SA; Geneva.<br /><searchLink fieldCode="AU" term="%22Van+der+Veen+L%22">Van der Veen L</searchLink>; iOnctura BV; Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Di+Conza+G%22">Di Conza G</searchLink>; iOnctura SA; Geneva.<br /><searchLink fieldCode="AU" term="%22Bertoni+F%22">Bertoni F</searchLink>; Institute of Oncology Research, Faculty of Biomedical Sciences, USI; Bellinzona, Switzerland; Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale; Bellinzona. francesco.bertoni@ior.usi.ch.<br /><searchLink fieldCode="AU" term="%22Brown+JR%22">Brown JR</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School; Boston, Massachusetts, USA; Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Boston, MA. jennifer_brown@dfci.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220417435%22">Haematologica</searchLink> [Haematologica] 2025 Dec 01; Vol. 110 (12), pp. 2974-2985. <i>Date of Electronic Publication: </i>2025 Jun 19.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ferrata+Storti+Foundation%22">Ferrata Storti Foundation </searchLink><i>Country of Publication: </i>Italy <i>NLM ID: </i>0417435 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1592-8721 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203906078%22">03906078 </searchLink><i>NLM ISO Abbreviation: </i>Haematologica <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40534489
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3324/haematol.2024.287180
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2974
    Titles:
      – TitleFull: Novel PI3kδ inhibitor roginolisib synergizes with venetoclax in hematologic malignancies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sasi BK
      – PersonEntity:
          Name:
            NameFull: Tarantelli C
      – PersonEntity:
          Name:
            NameFull: Martindale S
      – PersonEntity:
          Name:
            NameFull: Civanelli E
      – PersonEntity:
          Name:
            NameFull: Cannas E
      – PersonEntity:
          Name:
            NameFull: Sartori G
      – PersonEntity:
          Name:
            NameFull: Arribas AJ
      – PersonEntity:
          Name:
            NameFull: Fernandes SM
      – PersonEntity:
          Name:
            NameFull: Shupe SJ
      – PersonEntity:
          Name:
            NameFull: Machado JH
      – PersonEntity:
          Name:
            NameFull: Tyekucheva S
      – PersonEntity:
          Name:
            NameFull: Ren Y
      – PersonEntity:
          Name:
            NameFull: Lahn M
      – PersonEntity:
          Name:
            NameFull: Van der Veen L
      – PersonEntity:
          Name:
            NameFull: Di Conza G
      – PersonEntity:
          Name:
            NameFull: Bertoni F
      – PersonEntity:
          Name:
            NameFull: Brown JR
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: 2025 Dec 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1592-8721
          Numbering:
            – Type: volume
              Value: 110
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Haematologica
              Type: main
ResultId 1